Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLR350 versus Dianeal PD-2 in chronic renal failure patients on CAPD in Japan
ISRCTN48112900Phase 3Completed
- Sponsor
- Baxter International Inc.
- Start
- Nov 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of Reguneal HCa and glucose-based peritoneal dialysate in chronic kidney disease (CKD) (2 arms), sponsored by Baxter International Inc. Primary endpoints: Peritoneal creatinine clearance and Ultrafiltration volume. Started Nov 2002; status: completed.
02
Drugs
Reguneal HCaglucose-based peritoneal dialysate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ISRCTN48112900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN48112900.